Tower Research Capital LLC (Trc) Poly Pid Ltd. Transaction History

Tower Research Capital LLC (Trc)

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$4.35 - $5.76 $5,006 - $6,629	1,151 Added 114.07%	2,160 $10,000
Q1 2022 May 12, 2022	BUY	$3.92 - $6.25 $3,955 - $6,306	1,009 New	1,009 $6,000
Q3 2021 Nov 15, 2021	SELL	$7.05 - $9.48 $2,305 - $3,099	-327 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$8.4 - $9.99 $16,976 - $20,189	-2,021 Reduced 86.07%	327 $3,000
Q1 2021 May 17, 2021	BUY	$8.92 - $15.5 $4,906 - $8,525	550 Added 30.59%	2,348 $22,000
Q4 2020 Feb 16, 2021	BUY	$8.89 - $13.5 $15,984 - $24,273	1,798 New	1,798 $18,000

Ticker PYPD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 19,551,200
Market Cap $59.2M
Description
PolyPid Ltd., a late-stage biopharma company, develops, manufactures, and commercializes products based on polymer-lipid encapsulation matrix (PLEX) platform to address unmet medical needs. Its lead product candidate is D-PLEX100, which is in Phase III clinical trial for the prevention of sternal (bone) surgical site infections (SSIs), as well a...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.